Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel

Anupam Rama Analyst Performance

Analyst at JPMorgan Chase & Co.

Anupam Rama is a stock analyst at JPMorgan Chase & Co. focused in the healthcare sector, covering 43 publicly traded companies. Over the past year, Anupam Rama has issued 63 stock ratings, including buy, hold, and sell recommendations. While full access to Anupam Rama's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Anupam Rama's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
135 Last 10 Years
Buy Recommendations
81.48% 110 Buy Ratings
Companies Covered
43 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy81.5%110 ratings
Hold14.8%20 ratings
Sell3.7%5 ratings

Out of 135 total stock ratings issued by Anupam Rama at JPMorgan Chase & Co., the majority (81.5%) have been Buy recommendations, followed by 14.8% Hold and 3.7% Sell.

Best & Worst Calls

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
43 companies

Anupam Rama, an analyst at JPMorgan Chase & Co., currently covers 43 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
42 companies		97.7%
Industrials
1 company		2.3%

Anupam Rama of JPMorgan Chase & Co. specializes in stock coverage within the Healthcare sector, with additional focus on Industrials companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
40 companies		93.0%
PHARMACEUTICALS
2 companies		4.7%
ELECTRICAL EQUIPMENT
1 company		2.3%

Anupam Rama's Ratings History at JPMorgan Chase & Co.

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
Export
CompanyReport DateActionReport Date Price12-Month
Price Target		Rating12-Month
Price & ROI		Details
Kiniksa Pharmaceuticals International, plc stock logo
KNSA
Kiniksa Pharmaceuticals International
7/29/2026Boost Price Target$81.03$107.00Overweight
KARD
Kardigan
7/13/2026Initiated Coverage$24.64$51.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
6/26/2026Upgrade$10.95$17.00Overweight
CAMP4 Therapeutics Corporation stock logo
CAMP
CAMP4 Therapeutics
6/16/2026Upgrade$3.96$9.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
5/29/2026Upgrade$8.61$8.00Neutral
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
5/8/2026Boost Price Target$152.28$185.00Overweight
TRAX
First Tracks Biotherapeutics
4/23/2026Initiated Coverage$18.87$31.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
4/13/2026Reiterated Rating$4.77Underweight
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
4/1/2026Reiterated Rating$40.39$41.00Neutral
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
3/31/2026Boost Price Target$30.20$58.00Overweight
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
3/25/2026Lower Price Target$27.14$41.00Overweight
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
3/25/2026Boost Price Target$7.28$12.00Overweight
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/18/2026Boost Price Target$14.45$58.00Overweight
Erasca, Inc. stock logo
ERAS
Erasca
3/18/2026Boost Price Target$13.51$25.00Overweight
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
3/18/2026Lower Price Target$18.92$32.00Overweight
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
3/16/2026Upgrade$7.86$12.00Overweight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
3/12/2026Boost Price Target$128.49$177.00Overweight
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
3/12/2026Lower Price Target$21.44$74.00Overweight
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
3/11/2026Reiterated Rating$21.31$21.50Neutral
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
3/10/2026Boost Price Target$74.18$94.00Overweight
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
3/9/2026Boost Price Target$24.74$45.00Overweight
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
3/5/2026Boost Price Target$20.15$37.00Overweight
AgomAb Therapeutics NV stock logo
AGMB
AgomAb Therapeutics
3/3/2026Initiated Coverage$16.21$32.00Overweight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/17/2026Lower Price Target$128.66$176.00Overweight
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
2/5/2026Lower Price Target$17.25$39.00Overweight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
1/12/2026Lower Price Target$132.91$177.00Overweight
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
12/19/2025Lower Price Target$50.24$96.00Overweight
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
12/19/2025Boost Price Target$38.89$67.00Overweight
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
12/19/2025Lower Price Target$12.84$40.00Overweight
Nuvalent, Inc. stock logo
NUVL
Nuvalent
12/19/2025Lower Price Target$103.23$145.00Overweight
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
12/9/2025Initiated Coverage$8.36$43.00Overweight
Novavax, Inc. stock logo
NVAX
Novavax
11/18/2025Lower Price Target$6.56$6.00Underweight
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
11/18/2025Boost Price Target$11.70$20.00Overweight
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
11/18/2025Boost Price Target$21.48$32.00Overweight
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
11/17/2025Downgrade$217.78Neutral
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
11/14/2025Initiated Coverage$11.72$17.00Overweight
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
11/12/2025Lower Price Target$16.78$33.00Overweight
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
11/12/2025Boost Price Target$29.58$57.00Overweight
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
11/7/2025Boost Price Target$9.74$27.00Overweight
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
11/7/2025Boost Price Target$62.11$77.00Overweight
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
11/7/2025Lower Price Target$24.17$52.00Overweight
Amicus Therapeutics, Inc. stock logo
FOLD
Amicus Therapeutics
11/6/2025Boost Price Target$8.90$19.00Overweight
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
11/5/2025Lower Price Target$20.02$36.00Overweight
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
11/5/2025Lower Price Target$3.96$11.00Overweight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
11/3/2025Boost Price Target$140.28$179.00Overweight
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
10/24/2025Upgrade$17.11$24.00Overweight
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
10/23/2025Boost Price Target$28.58$79.00Overweight
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
10/21/2025Boost Price Target$16.22$44.00Overweight
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
10/20/2025Upgrade$36.85$55.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
10/20/2025Upgrade$8.93$11.00Neutral
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
10/10/2025Initiated Coverage$110.76$200.00Overweight
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
9/29/2025Boost Price Target$27.00$37.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
9/19/2025Reiterated Rating$3.46Underweight
CAMP4 Therapeutics Corporation stock logo
CAMP
CAMP4 Therapeutics
9/16/2025Downgrade$2.74Neutral
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
9/3/2025Boost Price Target$52.20$70.00Overweight
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
9/3/2025Boost Price Target$25.93$74.00Overweight
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
8/14/2025Upgrade$8.62$15.00Neutral
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
8/14/2025Lower Price Target$6.27$13.00Overweight
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
8/14/2025Lower Price Target$9.71$17.00Overweight
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
8/14/2025Boost Price Target$5.24$29.00Overweight
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
8/7/2025Boost Price Target$10.79$30.00Overweight
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
8/7/2025Lower Price Target$19.72$53.00Overweight
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
8/4/2025Boost Price Target$24.26$37.00Overweight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
7/31/2025Boost Price Target$128.23$145.00Neutral
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
7/30/2025Upgrade$11.53$14.00Neutral
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/29/2025Upgrade$13.86$24.00Neutral
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
7/28/2025Boost Price Target$24.50$72.00Overweight
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/25/2025Reiterated Rating$12.89Underweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
7/24/2025Boost Price Target$26.91$80.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
7/22/2025Reiterated Rating$3.05$9.00Neutral
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/21/2025Lower Price Target$14.07$20.00Overweight
Replimune Group, Inc. stock logo
REPL
Replimune Group
7/16/2025Boost Price Target$12.40$19.00Overweight
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
7/10/2025Boost Price Target$11.02$29.00Overweight
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/10/2025Lower Price Target$19.01$28.00Overweight
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
5/29/2025Boost Price Target$5.22$25.00Overweight
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
5/22/2025Boost Price Target$19.04$66.00Overweight
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
5/20/2025Lower Price Target$37.68$84.00Overweight
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/28/2025Lower Price Target$4.20$28.00Overweight
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
3/27/2025Boost Price Target$38.88$117.00Overweight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
3/26/2025Boost Price Target$116.18$184.00Overweight
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
3/24/2025Boost Price Target$34.77$50.00Overweight
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
3/20/2025Boost Price Target$13.84$41.00Overweight
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
3/13/2025Boost Price Target$36.14$51.00Overweight
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
3/13/2025Lower Price Target$5.15$11.00Overweight
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
3/5/2025Boost Price Target$15.19$42.00Overweight
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
3/5/2025Lower Price Target$9.32$34.00Overweight
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
3/4/2025Boost Price Target$14.46$39.00Overweight
Apellis Pharmaceuticals, Inc. stock logo
APLS
Apellis Pharmaceuticals
3/4/2025Boost Price Target$24.65$54.00Overweight
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
3/4/2025Lower Price Target$28.66$71.00Overweight
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
2/26/2025Boost Price Target$21.45$44.00Overweight
Porter flew 3,300 miles to investigate this system (Ad)

Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel

Watch the full investigation and decide for yourself
Replimune Group, Inc. stock logo
REPL
Replimune Group
2/26/2025Boost Price Target$13.60$18.00Overweight
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/26/2025Boost Price Target$8.69$22.00Overweight
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
2/25/2025Initiated Coverage$10.82$30.00Overweight
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
2/6/2025Boost Price Target$12.72$21.00Overweight

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Top Stock Recommendations by Brokerage